| Literature DB >> 27113760 |
Shengjie Feng1, Shaorong Ma1, Caixia Jia2, Yujuan Su1, Shenglian Yang2, Kechun Zhou2, Yani Liu3, Ju Cheng1, Dunguo Lu2, Liu Fan2, Yizheng Wang4.
Abstract
Sonic hedgehog (Shh), both as a mitogen and as a morphogen, plays an important role in cell proliferation and differentiation during early development. Here, we show that Shh inhibits glutamate transporter activities in neurons, rapidly enhances extracellular glutamate levels, and affects the development of epilepsy. Shh is quickly released in response to epileptic, but not physiological, stimuli. Inhibition of neuronal glutamate transporters by Shh depends on heterotrimeric G protein subunit Gαi and enhances extracellular glutamate levels. Inhibiting Shh signaling greatly reduces epileptiform activities in both cell cultures and hippocampal slices. Moreover, pharmacological or genetic inhibition of Shh signaling markedly suppresses epileptic phenotypes in kindling or pilocarpine models. Our results suggest that Shh contributes to the development of epilepsy and suppression of its signaling prevents the development of the disease. Thus, Shh can act as a modulator of neuronal activity, rapidly regulating glutamate levels and promoting epilepsy.Entities:
Keywords: Epilepsy; extracellular glutamate; glutamate transporter; neuronal activity; sonic hedgehog
Mesh:
Substances:
Year: 2016 PMID: 27113760 PMCID: PMC5341526 DOI: 10.15252/embr.201541569
Source DB: PubMed Journal: EMBO Rep ISSN: 1469-221X Impact factor: 8.807